Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Tectal glioma harbors high rates of KRAS G12R and concomitant KRAS and BRAF alterations.

Acta neuropathologica - 1 Mar 2020

Chiang Jason, Li Xiaoyu, Liu Anthony P Y, Qaddoumi Ibrahim, Acharya Sahaja, Ellison David W

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Brain Neoplasms
Share to Child
Share to Child, Preschool
Share to Glioma

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mutation

Share to Proto-Oncogene Proteins B-raf

Share to Proto-Oncogene Proteins p21(ras)

Source

Open in PubMed Open full text

Identifiers

PMID: 31822998
DOI: 10.1007/s00401-019-02112-x
PMCID: PMC7725430

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Tectal glioma harbors high rates of KRAS G12R and concomitant KRAS and BRAF alterations.PMID 31822998Read ↗

Novel KRAS mutation in an unusual tectal low-grade glioma.Semantic proximity Read ↗

Atypical Molecular Features of Pediatric Tectal Glioma: A Single Institutional Series.Semantic proximity Read ↗

Low-grade BRAF V600E mutant oligodendroglioma-like tumors of children may show EGFR and MET amplification.Semantic proximity Read ↗

TRAM2 promotes the malignant progression of glioma through PI3K/AKT/mTOR pathwaySemantic proximity Read ↗

BRAFAMP Frequently Co-occurs With IDH1/2, TP53, and ATRX Mutations in Adult Patients With Gliomas and Is Associated With Poorer Survival Than That of Patients Harboring BRAFV600ESemantic proximity Read ↗

Targeting Ras-RAF-ERK and its Interactive Pathways as a Novel Therapy for Malignant GliomasSemantic proximity Read ↗

Infrequent RAS mutation is not associated with specific histological phenotype in gliomas.Semantic proximity Read ↗

Activated KRAS reprograms neural progenitor cells to glioma stem cell‑like phenotype.Semantic proximity Read ↗

Tovorafenib effective against low-grade gliomas harbouring BRAF fusions.Semantic proximity Read ↗

The role of BRAF-targeted therapy in astrocytomas: a review.Semantic proximity Read ↗

Oncogenic KRAS promotes malignant brain tumors in zebrafishSemantic proximity Read ↗

KRAS Mutation in Pediatric Intracranial Germ Cell Tumors.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.